Entrada Therapeutics (TRDA) EBT (2020 - 2026)
Entrada Therapeutics' (TRDA) quarterly EBT came in at -$39.7 million in Q1 2026, down 128.71% year-on-year from $138.2 million in Q1 2025, and down 1.55% quarter-over-quarter from -$39.1 million in Q4 2025.
Entrada Therapeutics (TRDA) EBT (2020 - 2026) Analysis & Trends
Entrada Therapeutics' EBT history runs 7 years deep, the most recent figure standing at -$39.7 million for Q1 2026.
- On a quarterly basis, EBT fell 128.71% year-over-year to -$39.7 million in Q1 2026; TTM through Mar 2026 was -$165.2 million, a 793.67% decrease from a year earlier, with the FY2025 full-year figure at -$142.8 million, down 314.82% from the prior year.
- EBT declined to -$39.7 million in Q1 2026 per TRDA's latest filing, from -$39.1 million in the prior quarter.
- Across five years, EBT topped out at $57.8 million in Q2 2024 and bottomed at -$43.5 million in Q3 2025.
- The 5-year median for EBT is -$17.3 million (2025), against an average of -$11.7 million.
- Across the five-year window, EBT soared 910.98% in 2024 and slumped 5187.14% in 2025, its largest moves.
- Year by year, EBT stood at -$24.6 million in 2022, then soared by 137.34% to $9.2 million in 2023, then plunged by 108.04% to -$739000.0 in 2024, then plunged by 5187.14% to -$39.1 million in 2025, then retreated by 1.55% to -$39.7 million in 2026.
- Per Business Quant, the three latest TRDA EBT figures stand at -$39.7 million (Q1 2026), -$39.1 million (Q4 2025), and -$43.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Entrada Therapeutics | 253.11 Mn | 253.11 Mn | - | -39.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.68 Mn |
| Dec 31, 2025 | -39.07 Mn |
| Sep 30, 2025 | -43.48 Mn |
| Jun 30, 2025 | -42.93 Mn |
| Mar 31, 2025 | -17.35 Mn |
| Dec 31, 2024 | -739,000.00 |
| Sep 30, 2024 | -15.89 Mn |
| Jun 30, 2024 | 57.79 Mn |
| Mar 31, 2024 | 25.33 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Sep 30, 2023 | 18.06 Mn |
| Jun 30, 2023 | -12.08 Mn |
| Mar 31, 2023 | -3.12 Mn |
| Dec 31, 2022 | -24.63 Mn |
| Sep 30, 2022 | -25.14 Mn |
| Jun 30, 2022 | -23.18 Mn |
| Mar 31, 2022 | -21.67 Mn |
| Dec 31, 2021 | -47.36 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -9.90 Mn |